Evidence map›Paper›PMID 29669921›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

A selective class of inhibitors for the CLC-Ka chloride ion channel.

Anna K Koster, Chase A P Wood, Rhiannon Thomas-Tran, Tanmay S Chavan, Jonas Almqvist, Kee-Hyun Choi, J Du Bois, Merritt Maduke

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Biophysical and Pharmacological Insights to CLC Chloride Channels.Handbook of experimental pharmacology · 2024
    Article
  6. Expanding Genotype-Phenotype Correlation ofInternational journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.Reviews of physiology, biochemistry and pharmacology · 2022
    Review
  11. Potassium and Chloride Ion Channels in Cancer: A Novel Paradigm for Cancer Therapeutics.Reviews of physiology, biochemistry and pharmacology · 2022
    Review
  12. Chloride transport modulators as drug candidates.American journal of physiology. Cell physiology · 2021
    Review
  13. Development and validation of a potent and specific inhibitor for the CLC-2 chloride channel.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  14. Article
  15. Article
  16. Taming unruly chloride channel inhibitors with rational design.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Anna K KosterDepartment of Chemistry, Stanford University, Stanford, CA 94305.
Chase A P WoodDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.
Rhiannon Thomas-TranDepartment of Chemistry, Stanford University, Stanford, CA 94305.
Tanmay S ChavanDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.
Jonas AlmqvistDepartment of Cell and Molecular Biology, Uppsala University, 751 24 Uppsala, Sweden.
Kee-Hyun ChoiMaterials and Life Science Research Division, Korea Institute of Science and Technology, 02792 Seoul, Republic of Korea.
J Du BoisDepartment of Chemistry, Stanford University, Stanford, CA 94305; jdubois@stanford.edu maduke@stanford.edu.
Merritt MadukeDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305; jdubois@stanford.edu maduke@stanford.edu.ORCID 0000-0001-7787-306X
Stanford University · USKorea Institute of Science and Technology · KRUppsala University · SE

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

CLC proteins are a ubiquitously expressed family of chloride-selective ion channels and transporters. A dearth of pharmacological tools for modulating CLC gating and ion conduction limits investigations aimed at understanding CLC structure/function and physiology. Herein, we describe the design, synthesis, and evaluation of a collection of

Indexed as

AnimalsBinding SitesChloride ChannelsChloridesElectrophysiologyHumansIon Channel GatingMolecular Docking SimulationMutagenesis, Site-DirectedMutationProtein ConformationSmall Molecule LibrariesStructure-Activity RelationshipXenopus laevisChloride ChannelsChloridesCLCNKA protein, humanSmall Molecule Librarieschloride channelelectrophysiologymolecular probes

Identifiers

PMID29669921
PMCPMC6003504
OpenAlexW2802995714

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.